FDA Adverse Event Malfunction Summary report: N

BARD® INLAY® URETERAL STENT

MDR report key: 23735154 · Received December 5, 2025

Report

Report Number
1018233-2025-10865
Event Type
Malfunction
Date Received
December 5, 2025
Date of Event
November 28, 2025
Report Date
May 8, 2026
Manufacturer
C.R. BARD INC. (COVINGTON) -1018233
Product Code
FAD
UDI-DI
00801741014833
PMA / PMN Number
K983498
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION IS STILL IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETE A SUPPLEMENTAL REPORT WILL BE FILED. UDI FORMAT UPDATED WITH AVAILABLE PRODUCT INFORMATION PER GUDID. H11: SECTIONS A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT LAPAROSCOPIC PARTIAL LEFT NEPHRECTOMY. TO PREVENT POSTOPERATIVE URINARY LEAKAGE, A DOUBLE-J STENT WAS PLACED IN THE URETER FOR INTERNAL DRAINAGE TO REDUCE RENAL PELVIC PRESSURE. A LEFT-SIDED DOUBLE-J STENT WAS INSERTED. AN F6 DOUBLE-J STENT WAS ATTEMPTED BUT ENCOUNTERED SIGNIFICANT DIFFICULTY DURING PLACEMENT OVER THE ZEBRA GUIDEWIRE. CONSIDERED FRICTION BETWEEN THE STENT LUMEN AND GUIDEWIRE, INITIALLY ATTRIBUTED TO INSUFFICIENT LUBRICATION. DESPITE ADEQUATE LUBRICATION, PLACEMENT REMAINED TIGHT, RAISING CONCERN FOR URETERAL STRICTURE. AN F5 URETERAL CATHETER WAS SUCCESSFULLY ADVANCED APPROXIMATELY 25 CM INTO THE URETER. SUBSEQUENTLY, AN F5 DOUBLE-J STENT WAS SELECTED AND SUCCESSFULLY PLACED OVER THE ZEBRA GUIDEWIRE TO THE TARGET LOCATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
493443 BARD® INLAY® URETERAL STENT URETERAL STENT FAD C.R. BARD INC. (COVINGTON) -1018233 NGKR0287 00801741014833

Patients

Seq Age Sex Outcome Treatment
1